C47H60N7o10P Guanosin, 5 '-mothylylylyl) Phosphoderhoryl] (ACI- (2-.

Canonesch Laachen

N # CCCOP (OCC4) (C5C = CC = 3C (OC) C = CC (NC (O) C (CC) C = C6CCOC) C = C) C) C) C) C) C) C) C) C) C) C) C) C) C) C) C) C) C) C) C) C.

Isomeresch Laachen

C (oc3 = c (n = c2) c (= o) n = c (c) c (c) c) c)) (C4) (C4 = C3 = C3 = C3 = C1 (Oc) c = c4) (c5 = cc = c (oc) c = c5) c6 = CC = CC = CC = C6

Inchi

InChI= 1S/C47H60N7O10P/c1-30(2)43(55)51-46-50-42-39(44(56)52-46)49-29-53(42)45-41(60-27-26-57-7)40(64-65(62-25-13-24-48)54( 31-18) 42-37 (59- (63-45) 28-61-45 (33-12-11-15-153,34-15,34-16--20-36 (500-340.18-15-3,7-34) 31-18-22-37 , 40-41,45h, 13,25-28h2,1-9h3, (H2,51.52.52.55.56) / T38-, 45-, 40-,55.55.55.55.56), 40--, 40-, 40-65,55.55.55.55.56) 41--, 40--, 40--, 40-9,55,55.55.55.55.56) 41--, 45-, 45--60,55.55.55.55.56) #_18-, 40---, 40---, 40---60,55.55.52.55.55.56) #_18-, 40---, 40--, 40-65,55.55.55.55.55.56)

Inchi Schlëssel

Ladcdgnebiqaau-sbcraqivsa-n

17 aner Nimm fir dës Substanz

Guanosin, 5 '-O- [BIS (4-Joretixophyl) Phenylmthyl] -2 '-O- (2-Joryxyethyl) -N- (2-Methyl-1-oxopropyl) -, 3 '- [2-cyanethyl Bis (1- Methylylylyramidite] (9ci); 17: PN: US20030212017 Page: 20 behaapt Sequenz; 18: PN: US20030211606 Säit: 20

behaapt Sequenz; 19: PN: US20040005569 Säit: 22 fuerdere Sequenz; 21: Pn: US20040006030 Page: 23 behaapt Sequenz; 21: 3,200400111440,7 Säit: 21-uféiert Seefers op der 21. PN: 21: PN: US2004001144049 Säit: D'Clated Weltflächeger Seefreeder; 22: pn: US20030198965 Pag

E: 20 behaapt Sequenz; 22: PN: US200400055550 Säit: 21. Fuerderunge Funktioun; 22.: SN: US200400144048 Säit: 21-opgerechent Seefruction;

22.: SN: US200400111440): 21 Reklammenetekféierung. 23.: D'CN: US2004000556565 Säit: 17-12 verännert Sequenzen; 23: pn: US20040

014051 PAGE: 23 Fuerderung Sequenz; 24: SN: US20040014699P99PIED: 21 behaapt Raum: 25: D'PN: US2004000029 Säit: 23 Verwaltung obligatoresch Seeit; 25: PN: Wo03106645 Page: 73 behaapt Sequenz; 96: PN: US20040005707 Säit: 21 verdeedegt Sequenz